Compare Nippon India Pharma Fund vs UTI Healthcare Fund
Nippon India Pharma Fund
EquitySectoral-Pharma
UTI Healthcare Fund
EquitySectoral-Pharma
Risk
Very High
Very High
Rating
2.0
4.0
Min SIP Amount
₹100
₹500
Expense Ratio
1.85
2.23
NAV
₹594.49
₹357.39
Fund Started
10 May 2004
01 Aug 2005
Fund Size
₹9166.40 Cr
₹1429.84 Cr
Exit Load
Exit load of 1% if redeemed within 1 month.
Exit load of 1% if redeemed within 30 days.
1 Year
2.10%
6.45%
3 Year
14.97%
19.57%
5 Year
11.98%
13.77%
Equity
97.31%
94.12%
Cash
2.67%
5.85%
Top 10 Holdings
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 11.71% |
Divi's Laboratories Ltd. | 7.10% |
Lupin Ltd. | 6.17% |
Cipla Ltd. | 6.01% |
Dr. Reddy's Laboratories Ltd. | 5.45% |
Apollo Hospitals Enterprise Ltd. | 4.89% |
Mankind Pharma Ltd. | 4.38% |
Sai Life Sciences Ltd. | 3.92% |
Ajanta Pharma Ltd. | 3.61% |
Glaxosmithkline Pharmaceuticals Ltd. | 3.11% |
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 7.62% |
Divi's Laboratories Ltd. | 6.15% |
Dr. Reddy's Laboratories Ltd. | 5.24% |
Ajanta Pharma Ltd. | 4.81% |
Gland Pharma Ltd. | 4.06% |
Alkem Laboratories Ltd. | 3.70% |
Apollo Hospitals Enterprise Ltd. | 3.03% |
Caplin Point Laboratories Ltd. | 3.02% |
Global Health Ltd. | 2.96% |
Lupin Ltd. | 2.89% |
Name
-
-
Start Date
-
-
Description
The scheme seeks to generate consistent returns by investing in equity / equity related or fixed income securities of pharma and other associated companies.
The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector.
Launch Date
10 May 2004
01 Aug 2005
